FDA Adverse Event Injury Summary report: N

ESSURE

MDR report key: 2041203 · Received March 29, 2011

Report

Report Number
2951250-2011-00016
Event Type
Injury
Date Received
March 29, 2011
Date of Event
February 24, 2011
Report Date
January 19, 2017
Manufacturer
BAYER PHARMA AG
Product Code
HHS
PMA / PMN Number
P020014
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

COMMENTS: CONFERRED WITH CONSULTING PHYSICIANS WHO SPOKE W/ REPORTING DOCTOR. THEY DISCUSSED THE POSSIBILITY OF SEEDING THE INFECTION INTO THE PELVIS AFTER DRAINING THE ABSCESS, AS OPPOSED TO PERFORMING A HYSTERECTOMY RIGHT THEN AND THERE. THE TWO DOCTORS BOTH THOUGHT IT WAS HIGHLY UNUSUAL (AND UNLIKELY) TO HAVE A PID FROM THE ESSURE PROCEDURE 2 YEARS LATER. CONCEPTUS HAS MADE THE CONSERVATIVE DECISION TO REPORT THIS EVENT ON THIS MDR, EVEN THOUGH NO DIRECT LINK BETWEEN THE DEVICES AND THE INFECTION HAVE BEEN MADE.

Additional Manufacturer Narrative · 1

DATA CORRECTION FOR US REPORTING: THE CODE KNH WAS REPLACED WITH HHS.

Description of Event or Problem · 1

ON (B)(6) 2011, DOCTOR REPORTED A PATIENT WHO HAD ESSURE PLACED IN (B)(6) 2009 BY ANOTHER DOCTOR. PATIENT REPORTED HAVING THE 3 MONTH POST PROCEDURE HSG WHICH DOCUMENTED TUBAL OCCLUSION. A FEW DAYS AGO, SHE PRESENTED TO THE EMERGENCY ROOM AT (B)(6) WITH FEVER, SEVERE PAIN, ELEVATED WBC CONSISTENT WITH SOME INFECTION PROCESS. LAPAROSCOPY PERFORMED, CORNUAL ABSCESSES DRAINED, IV-ANTIBIOTICS ADMINISTERED. ADDITIONAL FOLLOW-UP: PATIENT TAKEN BACK INTO OPERATING ROOM AFTER ABOUT 36 HOURS AND A LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY WAS PERFORMED. PHYSICIAN STATED HE DID NOT FEEL THE INFECTION WAS CAUSED BY THE ESSURE DEVICES, BUT THE POSSIBILITY THAT THEY CONTRIBUTED TO THE LACK OF RESPONSE TO ANTIBIOTICS. THE MORNING FOLLOWING THE HYSTERECTOMY, THE PATIENT'S CONDITION IMPROVED DRAMATICALLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ESSURE INSERT, TUBAL OCCLUSION HHS BAYER PHARMA AG ESS305 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention